| Analysis | Metabolite Name | Measured Value | Units | Group | Treatment | Sample Source |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | L-Alanine | 13.3 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 13.6 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 17 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 17.1 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 17.3 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 17.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 18.1 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 18.7 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 19.2 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 19.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 19.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 19.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 20.1 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 20.7 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 21.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 21.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 21.7 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 22.6 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 23.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 24 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 24.5 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 24.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 27 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 28.8 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 29.1 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 34.3 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 34.3 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 34.8 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 45.5 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Alanine | 210 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 222 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 265 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 277 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 278 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 360 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 369 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 377 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 397 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 403 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 405 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 406 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 418 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 434 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 444 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 476 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 478 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 483 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 505 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 507 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 532 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 569 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 575 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 633 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 642 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 688 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 713 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 734 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 768 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Alanine | 773 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|